Se foredrag med Professor Jeff Evans – «Can patients with unresectable BCLC B benefit from systemic therapy?»
Professor Jeff Evans, Clinical Lead at Institute of Cancer Sciences, University of Glasgow, UK
Professor Jeff Evans, Clinical Lead at Institute of Cancer Sciences, University of Glasgow, UK
For å se innholdet på denne siden må du være autorisert helsepersonell.